These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24848707)

  • 1. Identification of targets of Twist1 transcription factor in thyroid cancer cells.
    Di Maro G; Orlandella FM; Bencivenga TC; Salerno P; Ugolini C; Basolo F; Maestro R; Salvatore G
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1617-26. PubMed ID: 24848707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells.
    Orlandella FM; Di Maro G; Ugolini C; Basolo F; Salvatore G
    Oncotarget; 2016 Oct; 7(43):70575-70588. PubMed ID: 27661106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype.
    Salerno P; Garcia-Rostan G; Piccinin S; Bencivenga TC; Di Maro G; Doglioni C; Basolo F; Maestro R; Fusco A; Santoro M; Salvatore G
    J Clin Endocrinol Metab; 2011 May; 96(5):E772-81. PubMed ID: 21389145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
    Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A
    J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.
    Lv N; Shan Z; Gao Y; Guan H; Fan C; Wang H; Teng W
    Endocrine; 2016 Mar; 51(3):469-77. PubMed ID: 26289126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
    Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
    J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.
    Buehler D; Hardin H; Shan W; Montemayor-Garcia C; Rush PS; Asioli S; Chen H; Lloyd RV
    Mod Pathol; 2013 Jan; 26(1):54-61. PubMed ID: 22899291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid receptor coactivator-1 interacts with NF-κB to increase VEGFC levels in human thyroid cancer.
    Gao B; Guo L; Luo D; Jiang Y; Zhao J; Mao C; Xu Y
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29717026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The basic helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates Twist1 through an E-box element.
    Suzuki M; Sato F; Bhawal UK
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):390-5. PubMed ID: 25446074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1.
    Alexander NR; Tran NL; Rekapally H; Summers CE; Glackin C; Heimark RL
    Cancer Res; 2006 Apr; 66(7):3365-9. PubMed ID: 16585154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentivirus-mediated shRNA interference of trefoil factor 3 blocks cell viability, migration and invasion in the papillary thyroid carcinoma cells.
    Wu J; Zhang H; Zhang W; Zhang J; Lin X; Xue G; Gao F
    Neoplasma; 2018; 65(2):169-177. PubMed ID: 29534576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZIC1 is a putative tumor suppressor in thyroid cancer by modulating major signaling pathways and transcription factor FOXO3a.
    Qiang W; Zhao Y; Yang Q; Liu W; Guan H; Lv S; Ji M; Shi B; Hou P
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1163-72. PubMed ID: 24684457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability.
    Cantisani MC; Parascandolo A; Perälä M; Allocca C; Fey V; Sahlberg N; Merolla F; Basolo F; Laukkanen MO; Kallioniemi OP; Santoro M; Castellone MD
    Oncotarget; 2016 May; 7(19):28510-22. PubMed ID: 27058903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of HIF-2α, TWIST, and CXCR4 is associated with lymph node metastasis in papillary thyroid carcinoma.
    Wang N; Luo HJ; Yin GB; Dong CR; Xu M; Chen GG; Liu ZM
    Clin Dev Immunol; 2013; 2013():589423. PubMed ID: 24288553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
    Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
    Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
    Zhang H; Teng X; Liu Z; Zhang L; Liu Z
    J Exp Clin Cancer Res; 2015 Feb; 34(1):16. PubMed ID: 25887589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of TTF-1 or PAX-8 expression on proliferation and tumorigenicity in thyroid carcinomas.
    Dupain C; Ali HM; Mouhoub TA; Urbinati G; Massaad-Massade L
    Int J Oncol; 2016 Sep; 49(3):1248-58. PubMed ID: 27573549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TWIST1 correlates with Notch signaling pathway to develop esophageal squamous cell carcinoma.
    Fahim Y; Yousefi M; Izadpanah MH; Forghanifard MM
    Mol Cell Biochem; 2020 Nov; 474(1-2):181-188. PubMed ID: 32712748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.